Anesth Analg 2004;98:483-490
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000096183.49619.FC
OBSTETRIC ANESTHESIA
A Dose-Response Meta-Analysis of Prophylactic Intravenous Ephedrine for the Prevention of Hypotension During Spinal Anesthesia for Elective Cesarean Delivery
Anna Lee, MPH PhD,
Warwick D. Ngan Kee, MBChB MD, FANZCA, and
Tony Gin, MBChB MD, FANZCA, FRCA
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China
Address correspondence to Anna Lee, MPH, PhD, Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, China. Address e-mail to annalee{at}cuhk.edu.hk
We systematically reviewed available studies to determine the dose-response characteristics of prophylactic IV ephedrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. We searched for randomized controlled trials (RCTs) or cohort studiesobtained through MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and reference lists of published articlesin which two or more different doses of prophylactic IV ephedrine were used to prevent hypotension during spinal anesthesia for cesarean delivery. Four RCTs and one cohort study were found (total n = 390). There was a significant dose-response relationship in the RCTs pooled for hypotension (slope = -0.0128; 95% confidence interval [CI], -0.0213 to -0.0044), hypertension (slope = 0.0563; 95% CI, 0.0235 to 0.0892), and umbilical arterial pH (slope = -0.03; 95% CI, -0.05 to 0.00). The efficacy of ephedrine for preventing hypotension was small. At 14 mg, the number-needed-to-treat was only 7.6 (95% CI, 4.821.1), and this was the same as the number-needed-to-harm (7.6; 95% CI, 3.723.4). At larger doses, the likelihood of causing hypertension was actually more than that of preventing hypotension, and there was also a minor decrease in umbilical arterial pH.
IMPLICATIONS: The authors performed a systematic review of dose-response studies of IV bolus ephedrine for preventing hypotension during spinal anesthesia for cesarean delivery. Prophylactic ephedrine cannot be recommended. The efficacy is poor at smaller doses, whereas at larger doses, the likelihood of causing hypertension is actually more than that of preventing hypotension.
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Balestrieri
Combined Spinal-Epidural Anesthesia for Cesarean Delivery: The Dose-Dependent Effects of Hyperbaric Bupivacaine on Maternal Hemodynamics
Anesth. Analg.,
February 1, 2007;
104(2):
453 - 453.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van de Velde, D. Van Schoubroeck, J. Jani, A. Teunkens, C. Missant, and J. Deprest
Combined Spinal-Epidural Anesthesia for Cesarean Delivery: The Dose-Dependent Effects of Hyperbaric Bupivacaine on Maternal Hemodynamics
Anesth. Analg.,
February 1, 2007;
104(2):
453 - 454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. M. Aya, N. Vialles, and J. Ripart
Is Ephedrine the Best Vasopressor for Treating Spinal Anesthesia-Induced Hypotension in Patients with Pre-Eclampsia?
Anesth. Analg.,
December 1, 2006;
103(6):
1584 - 1584.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van de Velde, D. Van Schoubroeck, J. Jani, A. Teunkens, C. Missant, and J. Deprest
Combined spinal-epidural anesthesia for cesarean delivery: dose-dependent effects of hyperbaric bupivacaine on maternal hemodynamics.
Anesth. Analg.,
July 1, 2006;
103(1):
187 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Erkinaro, T. Kavasmaa, M. Pakkila, G. Acharya, K. Makikallio, S. Alahuhta, and J. Rasanen
Ephedrine and phenylephrine for the treatment of maternal hypotension in a chronic sheep model of increased placental vascular resistance
Br. J. Anaesth.,
February 1, 2006;
96(2):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|